RAC 2.35% $1.31 race oncology ltd

Yes there were many studies (around 40) that went all the way up...

  1. 2,501 Posts.
    lightbulb Created with Sketch. 9380
    Yes there were many studies (around 40) that went all the way up to Phase III. Bisantrene was even approved in France for the treatment of AML.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
0.030(2.35%)
Mkt cap ! $216.4M
Open High Low Value Volume
$1.33 $1.35 $1.30 $58.18K 44.11K

Buyers (Bids)

No. Vol. Price($)
1 790 $1.29
 

Sellers (Offers)

Price($) Vol. No.
$1.33 1474 1
View Market Depth
Last trade - 16.10pm 23/04/2024 (20 minute delay) ?
Last
$1.33
  Change
0.030 ( 3.11 %)
Open High Low Volume
$1.33 $1.35 $1.30 93222
Last updated 14.54pm 23/04/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.